Sinotherapeutics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	407.11	225.79	641.79	763.15	511.66
Short-Term Investments	-	-	107.21	44.09	-
Trading Asset Securities	339.34	507.74	-	-	-
Cash & Short-Term Investments	746.45	733.53	749	807.23	511.66
Cash Growth	1.76%	-2.07%	-7.21%	57.77%	17.85%
Accounts Receivable	86.25	110.97	78.47	71.27	44.09
Other Receivables	3.24	0.3	0.57	-	-
Receivables	89.49	111.27	79.04	71.27	44.09
Inventory	72.55	102.42	84.61	29.38	40.43
Other Current Assets	26.38	29.1	39.36	45.83	22.66
Total Current Assets	934.87	976.32	952.01	953.71	618.83
Property, Plant & Equipment	363.88	344.34	271.41	255.92	115.09
Long-Term Investments	84.27	64.42	64.2	49.1	69.99
Goodwill	16.22	18.39	18.39	18.39	-
Other Intangible Assets	14.98	21.65	27.59	32.47	41.16
Long-Term Deferred Tax Assets	19.01	19.33	14.29	16.45	16.08
Long-Term Deferred Charges	0.46	0.92	1.21	1.99	3.15
Other Long-Term Assets	4.41	7.94	12.54	4.3	1.5
Total Assets	1,438	1,453	1,362	1,332	865.81
Accounts Payable	25.86	16.75	13.34	8.42	8.01
Accrued Expenses	10.68	26.49	14.69	11.58	14.19
Current Portion of Long-Term Debt	0.02	-	-	-	-
Current Portion of Leases	-	0.01	0.06	0.32	0.78
Current Income Taxes Payable	2.97	6.97	1.28	0.45	7.85
Current Unearned Revenue	29.91	30.44	48.01	56.8	46.78
Other Current Liabilities	13.51	22.54	13.33	12.47	11.92
Total Current Liabilities	82.96	103.19	90.72	90.05	89.52
Long-Term Leases	-	-	0.02	1.2	3.66
Long-Term Unearned Revenue	58.43	74.72	58.09	61.12	64.62
Long-Term Deferred Tax Liabilities	2.25	2.39	2.53	2.68	2.82
Other Long-Term Liabilities	2.48	-	-	-	-
Total Liabilities	146.12	180.3	151.36	155.05	160.62
Common Stock	453.34	453.34	453.34	453.34	408
Additional Paid-In Capital	512.92	513.57	512.89	512.89	179.23
Retained Earnings	361.86	342.22	244.16	211.19	118.26
Treasury Stock	-36.13	-36.13	-	-	-
Comprehensive Income & Other	-0.02	-	-0.13	-0.15	-0.31
Shareholders' Equity	1,292	1,273	1,210	1,177	705.19
Total Liabilities & Equity	1,438	1,453	1,362	1,332	865.81
Total Debt	0.02	0.01	0.09	1.52	4.44
Net Cash (Debt)	746.43	733.53	748.92	805.71	507.22
Net Cash Growth	1.76%	-2.05%	-7.05%	58.85%	16.82%
Net Cash Per Share	1.73	1.61	1.59	1.91	1.24
Filing Date Shares Outstanding	366.74	449	449.15	453.34	408
Total Common Shares Outstanding	366.74	449	453.34	453.34	408
Working Capital	851.91	873.13	861.29	863.66	529.31
Book Value Per Share	3.52	2.84	2.67	2.60	1.73
Tangible Book Value	1,261	1,233	1,164	1,126	664.02
Tangible Book Value Per Share	3.44	2.75	2.57	2.48	1.63
Buildings	-	216.23	211.68	54.29	52.41
Machinery	-	183.49	160.89	145.6	135.93
Construction In Progress	-	80.75	15.35	153.61	4.68

Source: S&P Global Market Intelligence. Standard template. Financial Sources.